CannaPharmaRX Provides Corporate Update and Outlines Growth Strategy for 2026
CannaPharmaRX Expands Cannabis Exports, Projects $1M+ Q3 Revenue
CannapharmaRx Continues into New European Market with First Shipment Completed to Germany
CannapharmaRX Updates on Alberta Facility Progress and International Export Strategy
CannapharmaRx to Complete Additional Shipment in November
CannaPharmaRx Receives Multiple Purchase Orders and Begins Delivery of Product
Q1 2024 Financial Results
CannaPharmaRX GAAP EPS of -$0.03
CannaPharmaRx Achieves First Harvest Milestone
CannaPharmaRx Expands to Latin America with ICAN
CannaPharmaRx Targets High Growth in 2023
CannaPharmaRx Gains Key Certifications for Global Growth
CannapharmaRx Launches Global Cannabis Distribution
CannaPharmaRx Targets Global Cannabis Leadership
CannaPharmaRx Welcomes Dean Medwid as CEO
CannaPharmaRx Schedules Investor Update Call
CORRECTION FROM SOURCE: CannaPharmaRx to Host Investor Conference Call
CannaPharmaRx to Host Investor Conference Call
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.
